Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update

被引：51
|
作者：
Ciarallo, Anthony [1 ]
Rivera, Juan [2 ]
机构：
[1] McGill Univ, Hlth Ctr, Dept Med Imaging, Div Nucl Med, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada
[2] McGill Univ, Hlth Ctr, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2020年 / 215卷 / 02期
关键词：
differentiated thyroid cancer; DTC; I-131; radioactive iodine therapy; RAI; thyroid cancer; RADIOIODINE-REMNANT ABLATION; I-131; METAANALYSIS; PATIENT;
D O I：
10.2214/AJR.19.22626
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid cancer therapy protocols are evolving. The purpose of this article is to promote a modern approach to radioiodine therapy. CONCLUSION. This article highlights guidelines and position statements, summarizes the prognostication systems of thyroid cancer, and reviews which prescribed activities of I-131 are appropriate for each risk category.
引用
收藏
页码：285 / 291
页数：7
相关论文
共 50 条
  • [31] RADIOACTIVE IODINE THERAPY IN THYROID-CANCER
    BENUA, RS
    YEH, SDJ
    LEEPER, RD
    JOURNAL OF NUCLEAR MEDICINE, 1982, 23 (05) : P88 - P88
  • [32] Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
    Chung, Jae Hoon
    ENDOCRINOLOGY AND METABOLISM, 2013, 28 (03) : 157 - 163
  • [33] Risk Factors for Indeterminate Response After Radioactive Iodine Therapy in Patients With Differentiated Thyroid Cancer
    Jeong, Eugene
    Yoon, Joon-Kee
    Lee, Su Jin
    Soh, Euy Young
    Lee, Jeonghun
    An, Young-Sil
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 714 - 718
  • [34] Value of Radioactive iodine therapy for low risk differentiated thyroid cancer where is the gap of evidence?
    Anzai, Yoshimi
    Minoshima, Erika
    Abraham, Dev
    Hunt, Jason
    Wissler, Taylor
    Minoshima, Satoshi
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [35] Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
    Zhang, Lu
    Li, Zhi
    Zhang, Meng
    Zou, Huangren
    Bai, Yuke
    Liu, Yanlin
    Lv, Juan
    Lv, Ling
    Liu, Pengjie
    Deng, Zhiyong
    Liu, Chao
    MEDICAL ONCOLOGY, 2023, 40 (09)
  • [36] Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
    Lu Zhang
    Zhi Li
    Meng Zhang
    Huangren Zou
    Yuke Bai
    Yanlin Liu
    Juan Lv
    Ling Lv
    Pengjie Liu
    Zhiyong Deng
    Chao Liu
    Medical Oncology, 40
  • [37] Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer
    An, Jee Hyun
    Song, Kee-Ho
    Kim, Dong-Lim
    Kim, Suk Kyeong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2017, 45 (01) : 38 - 50
  • [38] Urinary iodine concentration and radioactive iodine therapeutic response in patients with differentiated thyroid cancer
    Jiang, Yuyan
    Jin, Jiahui
    Fan, Jingzheng
    Huang, Chao
    Jia, Qiang
    Tan, Jian
    He, Xianghui
    Zheng, Xiangqian
    Zhao, Yue
    Zhang, Qing
    Meng, Zhaowei
    Wang, Yan
    BIOMARKERS IN MEDICINE, 2021, 15 (11) : 879 - 890
  • [39] Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
    Cortas, Christos
    Charalambous, Haris
    LIFE-BASEL, 2024, 14 (01):
  • [40] Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer
    Slonimsky, Einat
    Tulchinsky, Mark
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (31) : 3812 - 3827
12345